1. United States Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Saluda Medical Inc CHESS Depository Interest

Saluda Medical Inc CHESS Depository Interest

AASX:SLD
0.27
AUD
0.00
(0.00%)
Mar 03Next Earn
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Company Profile APIChatGPT
CEO
Mike Mathias
Sector
Health technology
Industry
Medical specialties
Address
9401 James Avenue S Bloomington MN United States 55431
IPO Date
Dec 3, 2025
Website
saludamedical.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Saluda Medical, Inc. is a commercial-stage medical device company. It focuses on developing treatments for chronic neurological conditions using the Company’s novel neuromodulation platform. Evoke System, the firm’s first product, is designed to treat chronic neuropathic pain. The company was founded in 2013 and is headquartered in Bloomington, MN.